ReviewInternational journal of clinical practice2017

Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus.

Matthew J Budoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.